序号 |
标题 |
次数 |
作者 |
发布时间 |
82801 |
3,6-二肼基-1,2,4,5-四嗪(DHT) |
134 |
WYQ |
2024-12-03 |
82802 |
3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine;3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪 |
122 |
WYQ |
2024-12-03 |
82803 |
二肼基四嗪盐(DNOBT-DHT) |
151 |
WYQ |
2024-12-03 |
82804 |
3-氨基-1,2,4-三唑盐(DNOBT-3-AT) |
140 |
WYQ |
2024-12-03 |
82805 |
s-四嗪-水簇复合物是指四嗪类化合物与水分子或水簇(多个水分子形成的聚集体)形成的复合物 |
130 |
WYQ |
2024-12-03 |
82806 |
四嗪基UIO-66及其相关化合物 |
126 |
WYQ |
2024-12-03 |
82807 |
3,6-二甲酸-1,2,4,5-二氢四嗪(DHTZ) |
194 |
WYQ |
2024-12-03 |
82808 |
3,6-二吡啶基-1,2,4,5-四嗪(DPTZ) |
117 |
WYQ |
2024-12-03 |
82809 |
N–氧化–3,3′–偶氮双(6–氨基–1,2,4,5–四嗪)(DAATO) |
149 |
WYQ |
2024-12-03 |
82810 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪铅复合物(LCBTATz) |
112 |
WYQ |
2024-12-03 |
82811 |
四嗪修饰透明质酸(tetrazine-HA;tetrazine-hyaluronic acid) |
126 |
WYQ |
2024-12-03 |
82812 |
四嗪修饰四臂聚乙二醇(4arm PEG-Tz;4arm PEG-tetrazine) |
107 |
WYQ |
2024-12-03 |
82813 |
1,2,3-三唑-[4,5-e]-1,2,3,4-四嗪4,6二氧阴离子([TTDO]-) |
132 |
WYQ |
2024-12-03 |
82814 |
3,6-二(3-吡啶基)-1,2,4,5-四嗪(3-bptz) |
128 |
WYQ |
2024-12-03 |
82815 |
金纳米颗粒表面修饰四嗪五聚乙二醇活泼酯:AbTCO |
148 |
WYQ |
2024-12-03 |
82816 |
放射性核素标记四嗪分子:Tz-68Ga(Tetrazine-68Ga) |
243 |
WYQ |
2024-12-03 |
82817 |
3,6-二氨基-1,2,4,5-四嗪改性碳纳米管(CNTs) |
110 |
WYQ |
2024-12-03 |
82818 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪(4-bptz) |
132 |
WYQ |
2024-12-03 |
82819 |
1,4-二-(吡啶基)-2,3,5,6-四嗪(bipytz) |
139 |
WYQ |
2024-12-03 |
82820 |
四嗪(Tz)修饰的金纳米粒子(Tz-AuNps;Tetrazine-AuNps) |
147 |
WYQ |
2024-12-03 |
82821 |
68Ga-L-NETA-四嗪(Tz)分子探针 |
127 |
WYQ |
2024-12-03 |
82822 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz)与3,5-二硝基水杨酸盐(DNSA)的结合体(DAHTz·DNSA·H2O) |
141 |
WYQ |
2024-12-03 |
82823 |
3,6-二(2H-5-四唑基)-1,2,4,5-四嗪(BTT) |
178 |
WYQ |
2024-12-03 |
82824 |
1,1′-二甲基-5,5′-偶氮四嗪(DMATZ) |
89 |
WYQ |
2024-12-03 |
82825 |
稀土纳米颗粒NaGdF4修饰四嗪(NaGdF4-Tz) |
187 |
WYQ |
2024-12-03 |
82826 |
alkynyl-FA,炔基修饰叶酸 |
111 |
wyh |
2024-12-03 |
82827 |
6-(3,5-二甲基吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(DPTTz) |
143 |
WYQ |
2024-12-03 |
82828 |
6-(1H-吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(PTTz) |
137 |
WYQ |
2024-12-03 |
82829 |
白蛋白靶向的布洛芬-Gd-DOTA,Ibu-Gd-BSA NPs |
131 |
wyh |
2024-12-03 |
82830 |
Cy5.5-NKL,Cy5.5标记NKL新型探针 |
104 |
wyh |
2024-12-03 |
82831 |
DOTA修饰司帕沙星 , DOTA-SPFX |
124 |
wyh |
2024-12-03 |
82832 |
DOTA-PEG-GA, DOTA-聚乙二醇-GA |
94 |
wyh |
2024-12-03 |
82833 |
3,6-双(3,5-二甲基吡唑)-1,2,4,5-四嗪(BT) |
99 |
WYQ |
2024-12-03 |
82834 |
钆(Gd)金属配合物(Gd-DOTA) |
155 |
wyh |
2024-12-03 |
82835 |
3,6-双硝基胍基-1,2,4,5-四嗪双氨基胍盐(AG2DNGTz) |
115 |
WYQ |
2024-12-03 |
82836 |
3-(3,5-二甲基吡唑基)-6-苯基亚甲基腙-1,2,4,5-四嗪(DAHBTz) |
99 |
WYQ |
2024-12-03 |
82837 |
DOTA-Cy5.5-PS,DOTA-Cy5.5-聚苯乙烯 |
104 |
wyh |
2024-12-03 |
82838 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz) |
99 |
WYQ |
2024-12-03 |
82839 |
NH2-PEG-DOTA-PEG-NH2,氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
117 |
wyh |
2024-12-03 |
82840 |
P(VDF-TrFE)@DOTA-Gd@RGD ,复合压电纳米粒子 |
128 |
wyh |
2024-12-03 |
82841 |
双吡啶基配体3,6-二(4-吡啶基)-1,2,4,5-四嗪(DPT) |
159 |
WYQ |
2024-12-03 |
82842 |
四嗪-聚乙二醇-N-羟基琥珀酰亚胺酯偶联1,2-二硬脂酰基-sn-甘油基-3-磷酸乙醇胺-N-[氨基(聚乙二醇)-2000](DSPE-PEG2k-NH2) |
114 |
WYQ |
2024-12-03 |
82843 |
修饰Tetrazine的脂质分子(DSPE-PEG2k-PEG5-Tetrazine) |
136 |
WYQ |
2024-12-03 |
82844 |
3,6-双硝基胍基-1,2,4,5-四嗪双胍盐(G2DNGTz) |
126 |
WYQ |
2024-12-03 |
82845 |
3,6-双(3-硝基-1,2,4-噁二唑-5-胍基)-1,2,4,5-四嗪(NOG2Tz) |
148 |
WYQ |
2024-12-03 |